Hybrid nanopores and uses thereof for detection of analytes
The invention relates to a hybrid structure comprising perforated solid substrate having at least one nanopore perforating therethrough, and devices and uses thereof.
1. A method for analysis of at least one analyte in a sample comprising:
(i) applying a sample comprising at least one analyte or suspected to comprise at least one analyte onto a hybrid structure, wherein the hybrid structure comprises (a) a solid substrate having at least one nanopore perforating therethrough, and (b) at least one ring-like polypeptide situated at a region of said at least one nanopore, said region being selected from an opening of the nanopore and an interior region of said nanopore, wherein the binding of the at least one ring-like polypeptide to the nanopore is different from covalent binding, and wherein the at least one ring-like polypeptide is stable protein 1 (SP1);
(ii) permitting the sample to flow through the nanopore;
(iii) determining at least one of (a) presence or absence of an analyte in the sample, (b) identity of the analyte in the sample and (c) concentration of the analyte in the sample, wherein the at least one analyte is a protein, a polypeptide, an oligopeptide, a peptide, a ganglioside, a lipid, a phospholipid, a carbohydrate, a small molecule or a nucleic acid.
2. The method according to claim 1 , wherein the sample comprising the SP1 and the hybrid structure is formed in parallel with step (i).
3. The method according to claim 1 , comprising monitoring at least one measurable parameter related to the nanopore wherein the at least one measurable parameter is at least one of (i) change in current, (ii) time duration of change in the current and any combination thereof.
4. The method according to claim 1 , wherein the at least one measurable parameter related to the nanopore comprises change in current.
5. The method according to claim 1 , wherein the at least one measurable parameter comprises time duration of change in the current.
6. The method according to claim 1 , wherein the analyte is a protein, a polypeptide, an oligopeptide, or a peptide.
7. The method according to claim 1 , wherein the analyte is a ganglioside, a lipid, a phospholipid, a carbohydrate, a small molecule or a nucleic acid.
8. The method according to claim 1 , wherein the analyte is a double stranded nucleic acid or a single stranded nucleic acid.
9. The method according to claim 1 , wherein the analyte is DNA or RNA.
10. The method according to claim 1 , wherein the analyte is nucleic acid and is in a linear conformation.
11. The method according to claim 1 , wherein the sample is selected from bodily fluid, an isolated cell population and a cell preparation.
12. The method according to claim 1 , wherein the sample is bodily fluid and is selected from the group consisting of blood, serum, plasma, urine, cerebrospinal fluid, amniotic fluid, tear fluid, nasal wash, mucus, saliva, sputum, bronchioalveolar fluid, throat wash, vaginal fluid and semen.